Betterlife Pharma Stock Shares Owned By Insiders
| BETRF Stock | USD 0.06 0.02 22.67% |
BetterLife Pharma fundamentals help investors to digest information that contributes to BetterLife Pharma's financial success or failures. It also enables traders to predict the movement of BetterLife OTC Stock. The fundamental analysis module provides a way to measure BetterLife Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to BetterLife Pharma otc stock.
BetterLife |
BetterLife Pharma OTC Stock Shares Owned By Insiders Analysis
BetterLife Pharma's Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Current BetterLife Pharma Shares Owned By Insiders | 8.41 % |
Most of BetterLife Pharma's fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, BetterLife Pharma is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
| Competition |
Based on the latest financial disclosure, 8.406% of BetterLife Pharma are shares owned by insiders. This is 44.62% lower than that of the Healthcare sector and 40.72% lower than that of the Biotechnology industry. The shares owned by insiders for all United States stocks is 16.69% higher than that of the company.
BetterLife Shares Owned By Insiders Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses BetterLife Pharma's direct or indirect competition against its Shares Owned By Insiders to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of BetterLife Pharma could also be used in its relative valuation, which is a method of valuing BetterLife Pharma by comparing valuation metrics of similar companies.BetterLife Pharma is currently under evaluation in shares owned by insiders category among its peers.
BetterLife Fundamentals
| Return On Equity | -44.17 | |||
| Return On Asset | -4.05 | |||
| Current Valuation | 12.42 M | |||
| Shares Outstanding | 90.1 M | |||
| Shares Owned By Insiders | 8.41 % | |||
| Price To Book | 13.65 X | |||
| Gross Profit | (22.81 K) | |||
| EBITDA | (11.92 M) | |||
| Net Income | (12.16 M) | |||
| Cash And Equivalents | 14.41 K | |||
| Total Debt | 34.56 K | |||
| Debt To Equity | 0.25 % | |||
| Current Ratio | 0.04 X | |||
| Book Value Per Share | (0.12) X | |||
| Cash Flow From Operations | (11.2 M) | |||
| Earnings Per Share | (0.12) X | |||
| Beta | 1.62 | |||
| Market Capitalization | 9.49 M | |||
| Total Asset | 1.16 M | |||
| Net Asset | 1.16 M |
About BetterLife Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze BetterLife Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BetterLife Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BetterLife Pharma based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in BetterLife OTC Stock
BetterLife Pharma financial ratios help investors to determine whether BetterLife OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BetterLife with respect to the benefits of owning BetterLife Pharma security.